Vaccine against pandemic strains of influenza viruses

Details for Australian Patent Application No. 2006236910 (hide)

Owner Purdue Research Foundation The Government of the United States of America as Represented by the Secretary of the Department Health and Human Services, Centers for Disease Control and Prevention

Inventors Hoelscher, Mary; Sambhara, Suryaprakash; Mittal, Suresh K.; Bangari, Dinesh S.; Katz, Jacqueline

Agent Griffith Hack

Pub. Number AU-B-2006236910

PCT Pub. Number WO2006/113214

Priority 60/670,826 11.04.05 US

Filing date 10 April 2006

Wipo publication date 26 October 2006

Acceptance publication date 7 June 2012

International Classifications

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

C07K 14/11 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/113214 Priority application(s): WO2006/113214

7 June 2012 Application Accepted

  Published as AU-B-2006236910

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236927-Methods and apparatus for inserting an intraocular lens into an eye

2006236905-Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen